124 related articles for article (PubMed ID: 32237034)
1. Identification of kinesin family member 3B (KIF3B) as a molecular target for gastric cancer.
Yao FZ; Kong DG
Kaohsiung J Med Sci; 2020 Jul; 36(7):515-522. PubMed ID: 32237034
[TBL] [Abstract][Full Text] [Related]
2. KIF3B Promotes the Proliferation of Pancreatic Cancer.
Liu ZH; Dong SX; Jia JH; Zhang ZL; Zhen ZG
Cancer Biother Radiopharm; 2019 Aug; 34(6):355-361. PubMed ID: 31157987
[No Abstract] [Full Text] [Related]
3. FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients.
Hou XL; Ji CD; Tang J; Wang YX; Xiang DF; Li HQ; Liu WW; Wang JX; Yan HZ; Wang Y; Zhang P; Cui YH; Wang JM; Bian XW; Liu W
Sci Rep; 2017 Jun; 7(1):3153. PubMed ID: 28600569
[TBL] [Abstract][Full Text] [Related]
4. TRIM21 improves apatinib treatment in gastric cancer through suppressing EZH1 stability.
Ping M; Wang S; Guo Y; Jia J
Biochem Biophys Res Commun; 2022 Jan; 586():177-184. PubMed ID: 34856418
[TBL] [Abstract][Full Text] [Related]
5. Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo.
Zhou Q; Yu J; Zheng Q; Wu T; Ji Z; Zhuo Y
FEBS Open Bio; 2021 May; 11(5):1487-1496. PubMed ID: 31774623
[TBL] [Abstract][Full Text] [Related]
6. Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
Huang X; Liu F; Zhu C; Cai J; Wang H; Wang X; He S; Liu C; Yao L; Ding Z; Zhang Y; Zhang T
Dig Dis Sci; 2014 Apr; 59(4):795-806. PubMed ID: 24368420
[TBL] [Abstract][Full Text] [Related]
7. CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p.
Rong D; Lu C; Zhang B; Fu K; Zhao S; Tang W; Cao H
Mol Cancer; 2019 Feb; 18(1):25. PubMed ID: 30777076
[TBL] [Abstract][Full Text] [Related]
8. RNF168 promotes RHOC degradation by ubiquitination to restrain gastric cancer progression via decreasing HDAC1 expression.
Xu Y; Feng Y; Sun Z; Li Q
Biochem Biophys Res Commun; 2021 Jun; 557():135-142. PubMed ID: 33865221
[TBL] [Abstract][Full Text] [Related]
9. Increased expression levels of AURKA and KIFC1 are promising predictors of progression and poor survival associated with gastric cancer.
Jung J; Jeong H; Choi JW; Kim HS; Oh HE; Lee ES; Kim YS; Lee JH
Pathol Res Pract; 2021 Aug; 224():153524. PubMed ID: 34148003
[TBL] [Abstract][Full Text] [Related]
10. The role of TRPV1 ion channels in the suppression of gastric cancer development.
Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H
J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449
[TBL] [Abstract][Full Text] [Related]
11. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
Jiang Z; Wang X; Li J; Yang H; Lin X
J Cell Mol Med; 2018 Sep; 22(9):4377-4386. PubMed ID: 29992789
[TBL] [Abstract][Full Text] [Related]
12. Rab40b upregulation correlates with the prognosis of gastric cancer by promoting migration, invasion, and metastasis.
Li Y; Jia Q; Wang Y; Li F; Jia Z; Wan Y
Med Oncol; 2015 Apr; 32(4):126. PubMed ID: 25790780
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.
Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB
J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen‑like‑protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
Zhang Y; Qiao HX; Zhou YT; Hong L; Chen JH
Mol Med Rep; 2018 Aug; 18(2):1465-1472. PubMed ID: 29845203
[TBL] [Abstract][Full Text] [Related]
15. Positive feedback loop of IL-1β/Akt/RARα/Akt signaling mediates oncogenic property of RARα in gastric carcinoma.
Ren HY; Liu F; Huang GL; Liu Y; Shen JX; Zhou P; Liu WM; Shen DY
Oncotarget; 2017 Jan; 8(4):6718-6729. PubMed ID: 28035062
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma.
Nishimura Y; Komatsu S; Ichikawa D; Nagata H; Hirajima S; Takeshita H; Kawaguchi T; Arita T; Konishi H; Kashimoto K; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Br J Cancer; 2013 Apr; 108(6):1324-31. PubMed ID: 23422756
[TBL] [Abstract][Full Text] [Related]
17. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
18. miR-135a promotes gastric cancer progression and resistance to oxaliplatin.
Yan LH; Chen ZN; Li-Li ; Chen J; Wei WE; Mo XW; Qin YZ; Lin Y; Chen JS
Oncotarget; 2016 Oct; 7(43):70699-70714. PubMed ID: 27683111
[TBL] [Abstract][Full Text] [Related]
19. MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer.
Song J; Liu Y; Wang T; Li B; Zhang S
Biomed Pharmacother; 2020 Aug; 128():110246. PubMed ID: 32447210
[TBL] [Abstract][Full Text] [Related]
20. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
